Jacob Asset Management Of New York LLC Contrafect Corp Transaction History

Jacob Asset Management Of New York LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.79 - $4.45 $266,288 - $424,725	-95,444 Reduced 27.81%	247,775 $761,000
Q1 2022 May 12, 2022	SELL	$2.26 - $3.84 $150,925 - $256,439	-66,781 Reduced 16.29%	343,219 $1.25 Million
Q2 2021 Oct 04, 2021	BUY	$3.58 - $4.9 $1.47 Million - $2.01 Million	410,000 New	410,000 $1.8 Million

49.2K

Ticker CFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,332,700
Market Cap $1.18M
Description
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus...

Get notified when there are updates to the investment portfolio of Jacob Asset Management Of New York LLC, based on Form 13F filings with the SEC.

Stay updated on Jacob Asset Management Of New York LLC with notifications on news.